Diabetes Drug Therapy Market

Diabetes is group of metabolic disorder, often referred as diabetes mellitus, results in high blood glucose levels. Body cells use glucose as a source of energy and insulin is important for the cells to absorb this glucose. When the body cells loose the capacity to respond to the insulin or body is not capable of producing sufficient insulin, it leads to an increase in blood glucose levels in the body. This condition is referred to as diabetes. Depending on the cause of development, it is divided into three types, which includes type 1 diabetes (body loses the capacity of producing sufficient insulin), type 2 diabetes (most common and body cells do not respond to insulin) and gestational diabetes (occurs in pregnant women). Among these, type 2 diabetes is the most common type and affects over 90% of the global diabetic patients.

Diabetes Drug Therapy Market contains market size and forecasts of Diabetes Drug Therapy in Global, including the following market information:

• Global Diabetes Drug Therapy Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global top five companies in 2021 (%)

The global Diabetes Drug Therapy market was valued at 9980.8 million in 2021 and is projected to reach US$ 18920 million by 2028, at a CAGR of 9.6% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Oral Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Diabetes Drug Therapy include Abbott Laboratories, Mannkind Corporation, Bristol Myers Squibb, Medtronic, AstraZeneca, Eli Lilly and Company, GlaxoSmithKline, Sanofi and Novo Nordisk and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Diabetes Drug Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Diabetes Drug Therapy Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Diabetes Drug Therapy Market Segment Percentages, by Type, 2021 (%)

• Oral
• Subcutaneous
• Intravenous

Global Diabetes Drug Therapy Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Diabetes Drug Therapy Market Segment Percentages, by Application, 2021 (%)

• Online Pharmacies
• Hospital Pharmacies
• Retail Pharmacies

Global Diabetes Drug Therapy Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Diabetes Drug Therapy Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Diabetes Drug Therapy revenues in global market, 2017-2022 (estimated), ($ millions)
• Key companies Diabetes Drug Therapy revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Abbott Laboratories
• Mannkind Corporation
• Bristol Myers Squibb
• Medtronic
• AstraZeneca
• Eli Lilly and Company
• GlaxoSmithKline
• Sanofi
• Novo Nordisk
• Novartis International AG